Study finds potential therapeutic target for pediatric acute myeloid leukemia

Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology.

Read more: https://www.eurekalert.org/pub_releases/2021-05/n-sfp050421.php